The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience
Open accessAbstract
Background/purpose: Both curative resection and minimized in‐hospital mortality offer the only chance of long‐term survival in patients with hilar cholangiocarcinoma. The reported resectability rates for hilar cholangiocarcinoma have increased by virtue of combined major hepatectomy, but this procedure is technically demanding and still associated with a significant morbidity and mortality that must be carefully balanced against the chances of long‐term survival. Methods: Between January 2001 and December 2008, 350 patients with hilar cholangiocarcinoma underwent exploration for the purpose of potentially curative resection, of whom 302 (86.3%) were resected in the Department of Hepato‐Biliary Surgery and Liver Transplantation, Asan Medical Center, University of Ulsan College of Medicine. Combined hepatectomy was carried out in 268 (88.7%) of 302 resected patients. Major hemihepatectomy and parenchyma‐preserving hepatectomy were performed in 257 and 11 patients, respectively. Portal vein resection was associated in 40 (14.9%) of 268 hepatectomized patients. To control preoperative cholangitis and reduce risk of postoperative hepatic failure, biliary decompression through endoscopic and/or percutaneous transhepatic drainage and portal vein embolization were preoperatively applied in 329 (94.0%) of 350 explored patients and in 91 (54.2%) of 168 extended hepatectomized patients (154 right hemihepatectomy, 9 right trisectionectomy, 5 left trisectionectomy), respectively. Liver transplantation was not performed as primary treatment for hilar cholangiocarcinoma. Results: There were 5 cases (1.7%) of in‐hospital death after resection and 1 postoperative liver failure that was successfully treated with liver transplantation. Major complications were encountered in 23 patients (7.0%), and the overall morbidity rate was 43%. In 302 resections, 214 (70.9%) were curative resections (R0) and 88 (29.1%) were palliative resections (R1). The overall 1‐, 3‐ and 5‐year survival rates after resection, including in‐hospital deaths, were 84.6, 50.7 and 47.3% in the R0 group and 69.9, 33.3 and 7.5% in the R1 group, respectively. The 5‐year survival rate of extended hemihepatectomy of 36.4% was better than that of parenchyma‐preserving hepatectomy at 10.5%. Two significant predictive factors adversely affecting survival after resection were lymph node metastasis and incurability of surgery (P < 0.001). Two patients with vascular involvement who underwent concomitant hepatic artery and portal vein reconstruction are alive after more than 3 years. Conclusion: Preoperative biliary decompression and portal vein embolization enabled us to reduce in‐hospital deaths associated with extended hepatectomy for hilar cholangiocarcinoma. Major hemihepatectomy offers an increased survival because of the higher possibility of curative resection than bile duct resection alone and parenchyma‐preserving hepatectomy, but it still carries a certain mortality. Less extensive procedures can be conducted safely and are beneficial for aged patients in poor condition with a less advanced tumor stage if tumor‐free resectional margins are obtained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
International Union Against Cancer (UICC)
Turner, B. (2012) · The Statesman’s Yearbook · doi:10.1007/978-1-349-59541-9_43 · Cited by 720
Rea, D. J., Heimbach, J. K., Rosen, C. B., Haddock, M. G., Alberts, S. R., Kremers, W. K., Gores, G. J., & Nagorney, D. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179678.13285.fa · Cited by 693
Nagino, M., Kamiya, J., Nishio, H., Ebata, T., Arai, T., & Nimura, Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201482.11876.14 · Cited by 540
Kawasaki, S., Imamura, H., Kobayashi, A., Noike, T., Miwa, S., & Miyagawa, S.-I. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000074984.83031.02 · Cited by 330
Hepatectomy With Portal Vein Resection for Hilar Cholangiocarcinoma: Audit of 52 Consecutive Cases
Ebata, T., Nagino, M., Kamiya, J., Uesaka, K., Nagasaka, T., & Nimura, Y. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000094437.68038.a3 · Cited by 328
Surgical Management of Hilar Cholangiocarcinoma
Hemming, A. W., Reed, A. I., Fujita, S., Foley, D. P., & Howard, R. J. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160701.38945.82 · Cited by 324
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Sano, T., Shimada, K., Sakamoto, Y., Yamamoto, J., Yamasaki, S., & Kosuge, T. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217605.66519.38 · Cited by 217
What constitutes long term survival after surgery for hilar cholangiocarcinoma?
Klempnauer, J., Ridder, G. J., Werner, M., Weimann, A., & Pichlmayr, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970101)79:1<26::aid-cncr5>3.0.co;2-k · Cited by 197
Cited by
Nagino, M., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., & Nimura, Y. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182708b57 · Cited by 656
Cholangiocarcinoma: Current Knowledge and New Developments
Blechacz, B. (2017) · Gut and Liver · doi:10.5009/gnl15568 · Cited by 485
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Hilar cholangiocarcinoma: expert consensus statement
Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J.-N. (2015) · HPB · doi:10.1111/hpb.12450 · Cited by 414
Cholangiocarcinoma—controversies and challenges
Patel, T. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.20 · Cited by 337
Metadata
- Authors
- Lee, S. G., Song, G. W., Hwang, S., Ha, T. Y., Moon, D. B., Jung, D. H., Kim, K. H., Ahn, C. S., Kim, M. H., Lee, S. K., Sung, K. B., & Ko, G. Y.
- Venue
- Journal of Hepato-Biliary-Pancreatic Sciences
- Publisher
- Wiley
- Published
- 2009-10-23
- Volume
- 17
- Issue
- 4
- Pages
- 476-489
- ISSN
- 1868-6974 (ISSN-L)
- 1868-6982
- OpenAlex
- W2147796106
- Cited by
- 259
- References
- 14
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. https://app.cochat.ai/papers/10.1007/s00534-009-0204-5
- The paper
- Lee, S. G., Song, G. W., Hwang, S., Ha, T. Y., Moon, D. B., Jung, D. H., Kim, K. H., Ahn, C. S., Kim, M. H., Lee, S. K., Sung, K. B., & Ko, G. Y. (2010). Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1007/s00534-009-0204-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.